scholarly journals Efficacy and Safety of Tralokinumab Monotherapy in Adult Patients with Moderate-to-Severe Atopic Dermatitis: Results from Two 52-Week, Phase 3 Trials (ECZTRA 1 and ECZTRA 2)

2020 ◽  
Vol 4 (6) ◽  
pp. s96
Author(s):  
Eric Simpson ◽  
Andrew Blauvelt ◽  
Emma Guttman-Yassky ◽  
Margitta Worm ◽  
Charles Lynde ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Adult Patients ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Phase 3

Abstract not available.

scholarly journals Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

The Lancet ◽  
2020 ◽  
Vol 396 (10246) ◽  
pp. 255-266 ◽  
Author(s):  
Eric L Simpson ◽  
Rodney Sinclair ◽  
Seth Forman ◽  
Andreas Wollenberg ◽  
Roland Aschoff ◽  
...  
Keyword(s):  
Atopic Dermatitis ◽  
Severe Atopic Dermatitis ◽  
Efficacy And Safety ◽  
Phase 3 ◽  
Double Blind
Sign in / Sign up

Export Citation Format

Share Document